Do you want to read an article? Please log in or register.
Rethinking Blood Eosinophils for Assessing ICS Response in COPD: A Post-Hoc Analysis from FLAME
Further Publications
RECOMMENDED
Related content
RECOMMENDED
Further Publications
Benefits of budesonide/glycopyrronium/formoterol fumarate dihydrate on lung function and exacerbations of COPD: a post-hoc analysis of the KRONOS study by blood eosinophil level and exacerbation history
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Respir Res
Muro S, Kawayama T, Sugiura H, Seki M, Duncan EA, Bowen K, Marshall J, Megally A, Patel M
doi: 10.1186/s12931-024-02918-8
COMMENTED
COPD
Reduced treatment response to inhaled corticosteroids in current smokers with COPD, regardless of blood eosinophil count: insights from the FLAME trial
★ 3
Recommended and commented by
Dr Martin Frey, Faculty Member
Thorax
Mathioudakis AG, Higham A, Bate S, Chatzimavridou-Grigoriadou V, Sivapalan P, Jensen JS, Felton T, Vestbo J, Singh D
doi: 10.1136/thorax-2024-222547
RECOMMENDED
Further Publications
Performance of risk assessment models for venous thromboembolism in critically ill patients receiving pharmacologic thromboprophylaxis: a post hoc analysis of the PREVENT trial
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Chest
Al-Dorzi HM, Arishi H, Al-Hameed FM, Burns KE, Mehta S, Jose J, Alsolamy SJ, Ann I Abdukahil S, Afesh LY, Alshahrani MS, Mandourah Y, Almekhlafi GA, Almaani M, Al Bshabshe A, Finfer S, Arshad Z, Khalid I, Mehta Y, Gaur A, Hawa H, Buscher H, Lababidi H, Al Aithan A, Al-Dawood A, Arabi YM, Saudi Critical Care Trials Group
doi: 10.1016/j.chest.2024.07.182
COPD
Step up to triple therapy versus switch to dual bronchodilator therapy in patients with COPD on an inhaled corticosteroid/long-acting β(2)-agonist: post-hoc analyses of KRONOS
Respir Res
Singh D, Bafadhel M, Arya N, Marshall J, Parikh H, Kisielewicz D, Movitz C, Bowen K, Patel M
doi: 10.1186/s12931-025-03234-5
RECOMMENDED
COPD
CRP, Fibrinogen, White Blood Cells, and Blood Cell Indices as Prognostic Biomarkers of Future COPD Exacerbation Frequency: The TIE Cohort Study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
J Clin Med
Ellingsen J, Janson C, Bröms K, Hårdstedt M, Högman M, Lisspers K, Palm A, Ställberg B, Malinovschi A
doi: 10.3390/jcm13133855
RECOMMENDED
Asthma
The Effect of Mepolizumab on Blood Eosinophil Subtype Distribution and Granule Protein Gene Expression in Severe Eosinophilic Asthma
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
J Asthma Allergy
Rimkunas A, Januskevicius A, Vasyle E, Palacionyte J, Kalinauskaite-Zukauske V, Miliauskas S, Malakauskas K
doi: 10.2147/JAA.S509001
ERS 2024
Asthma
TRAVERSE: Dupilumab reduces severe asthma exacerbation rates and improves lung function regardless of increases in blood eosinophil counts
COMMENTED
COPD
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype
★ 3
Recommended and commented by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
N Engl J Med
Sciurba FC, Criner GJ, Christenson SA, Martinez FJ, Papi A, Roche N, Bourbeau J, Korn S, Bafadhel M, Han MK, Kolterer S, Miller K, Mouneimne D, Fletcher J, Mayer B, Min J, Pavord ID, MATINEE Study Investigators
doi: 10.1056/NEJMoa2413181
COPD
Prevalence and Burden of Loneliness in COPD: A Systematic Review and Meta-analysis
Respir Med
Alqahtani JS, Arowosegbe A, Aldhahir AM, Alghamdi SM, Alqarni AA, Siraj RA, AlDraiwiesh IA, Alwafi H, Oyelade T
doi: 10.1016/j.rmed.2024.107768